ArticleScientific reports2025
Hydrogel dressing containing natural extracts inhibits dual-species biofilms of Staphylococcus aureus and Acinetobacter baumannii in ex vivo wound infection models.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Wound infections represent a significant cause of delayed wound healing. An active wound dressing was developed by incorporating extracts of Rhodomyrtus tomentosa leaf and Quercus infectoria gall in a carboxymethyl cellulose hydrogel (RQ hydrogel). In a modified artificial wound bed mimicking chronic wound infections, RQ hydrogel could inhibit up to 7 log CFU/mL of pathogens in both single- and dual-species biofilms. Antibacterial efficacy was further assessed in three different ex vivo porcine skin wound infection models. Model I: Ex vivo skin infection, the skin was exposed to dual cutures of Staphylococcus aureus/Acinetobacter baumannii. Topical application of RQ hydrogel resulted in 5 log CFU/mL reduction within 6 h. Model II: Ex vivo burn wound infection, more than 3 log CFU/mL of dual-species cultures were inhibited after treatment with RQ hydrogel. Model III: Ex vivo biofilms, preformed biofilms were established by culturing the pathogens on pig skin for 24 h in culture media containing wound exudates, followed by the application of RQ hydrogel on the preformed biofilms. Reduced bacterial biofilms were observed as indicated by decreased fluorescence intensity. Moreover, scanning electron microscopy confirmed the ex vivo inhibitory effects of RQ hydrogel.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.